Evidence map›Paper›PMID 20375230›Full record

ArticleJournal of clinical microbiology2010

Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease.

Susan E Sharp, Lila O Ruden, Julie C Pohl, Patricia A Hatcher, Linda M Jayne, W Michael Ivie

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Comparative evaluation of the STANDARD M10 and XpertJournal of clinical microbiology · 2024
    Article
  3. Article
  4. Rapid Quantification ofAnalytical chemistry · 2022
    Article
  5. Review
  6. Reduction in Health Care Facility-OnsetMayo Clinic proceedings. Innovations, quality & outcomes · 2021
    Article
  7. Article
  8. Article
  9. Laboratory Tests for the Diagnosis ofClinics in colon and rectal surgery · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Current knowledge on the laboratory diagnosis ofWorld journal of gastroenterology · 2017
    Review
  14. Review
  15. Article
  16. Article
  17. The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  18. An agent-based simulation model for Clostridium difficile infection control.Medical decision making : an international journal of the Society for Medical Decision Making · 2015
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Susan E SharpKaiser Permanente-NW, 13705 N.E. Airport Way, Portland, OR 97230, USA. susan.e.sharp@kp.org
Lila O Ruden
Julie C Pohl
Patricia A Hatcher
Linda M Jayne
W Michael Ivie

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of Clostridium difficile infection continues to be a challenge for many clinical microbiology laboratories. A new lateral flow assay, the C.Diff Quik Chek Complete assay, which tests for the presence of both glutamate dehydrogenase (GDH) and C. difficile toxins A and B, was evaluated for its ability to diagnose C. difficile disease. The results of this assay were compared to those of both PCR and toxigenic culture. The results showed that this assay allows 88% of specimens to be accurately screened as either positive (both tests positive) or negative (both tests negative) for the presence of toxigenic C. difficile in less than 30 min and with minimal hands-on time. Use of a random-access PCR for the analysis of specimens with discrepant results (one test positive and the other negative) allows the easy, rapid, and highly sensitive (100%; 95% confidence interval [CI], 89.6 to 100%) and specific (99.6%; 95% CI, 97.3 to 99.9%) diagnosis of C. difficile disease. The use of this algorithm would save institutional costs, curtail unnecessary isolation days, reduce the nosocomial transmission of disease, and increase the quality of care for patients.

Indexed as

Chemistry Techniques, AnalyticalBacterial ProteinsBacterial ToxinsBacteriological TechniquesClostridioides difficileEnterocolitis, PseudomembranousEnterotoxinsGlutamate DehydrogenaseHumansMass ScreeningSensitivity and SpecificityTime FactorsBacterial ProteinsBacterial ToxinsEnterotoxinsGlutamate DehydrogenasetcdA protein, Clostridium difficiletoxB protein, Clostridium difficile

Identifiers

PMID20375230
PMCPMC2884466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.